Yuanbao (YB): Chinese online insurance at a dirt-cheap price

2026-07-07 · By Lubin Danilo, founder of Lubin Investment

YB: see the full analysis on Lubin Investment

Yuanbao distributes health and life insurance online in China and passes all 10 criteria in my screener, with revenue up 72.6% a year on average over 5 years. Yet the stock trades at barely 0.5 times its free cash flow, one of the lowest valuations in my entire tracked universe, a sign of the geopolitical risk the market attaches to Chinese stocks listed abroad.

Key takeaways

• Yuanbao passes all 10 criteria in my screener, with revenue up 72.6% a year on average over 5 years.
• The stock trades at barely 0.5 times its annual free cash flow, one of the lowest valuations in my entire tracked universe.
• The company has been profitable for 13 straight quarters, a rare stability signal for a still fast-growing tech platform.
• Its risk profile (Chinese ADR, regulatory restrictions, delisting risk) is similar to Futu Holdings, already analyzed on my site.

What Yuanbao does

Yuanbao is a Chinese platform that distributes health and life insurance products online, connecting Chinese consumers to offers from multiple insurance companies through a digital interface rather than a traditional agent network. This digital distribution model sharply cuts customer acquisition costs compared to traditional insurance, while offering consumers more choice and pricing transparency.

Extraordinary growth and financial quality

Yuanbao passes all ten of my financial criteria, with revenue up 72.6% a year on average over five years and free cash flow per share up 275.8% a year over the same period. Net margin reaches 29.9% and cash return on invested capital hits 53.8%, exceptional levels for a still fast-growing company. The company has been profitable for 13 straight quarters, a stability signal that contrasts with the image often attached to fast-growing but loss-making Chinese tech platforms.

Why the stock trades so low

At a P/FCF of roughly 0.5, Yuanbao trades at less than half a year of its current free cash flow, one of the most extreme discounts in my entire screener. A price this low, despite near-perfect financial quality, signals the market is pricing in a risk far broader than the company's fundamentals alone: the risk attached to Chinese stocks listed abroad as ADRs (American Depositary Receipts).

The parallel with Futu Holdings

I've already analyzed Futu Holdings, the Hong Kong-based online broker, which shows a similar risk profile: potential restrictions on capital flows, Chinese regulation that can shift quickly and without warning for tech companies, and a delisting risk from US markets raised several times in recent years for Chinese companies listed in the United States. This isn't a distant hypothetical risk: it's a factor that concretely weighs on the valuation of every Chinese stock listed abroad, regardless of the quality of its fundamentals.

Yuanbao's moat

Yuanbao's moat comes from its technology platform and customer database, which lets it refine insurance product recommendations and reduce marketing costs over time. In a still-fragmented Chinese online insurance market, that technological edge and scale are a real advantage, though less structurally protected than a regulatory monopoly.

Risks to know before looking closer

Beyond the geopolitical risk already mentioned, an investor must accept accounting transparency and governance sometimes less established than a Western company listed for decades, along with full exposure to Chinese financial and tech sector regulation, which can change quickly. These are real risks, not secondary details, to weigh seriously against the valuation discount.

What I take away from this

Yuanbao illustrates an extreme case where financial quality and price tell two completely different stories: the numbers describe a remarkable company, the price describes a risk the market judges considerable. I never settle this kind of case on numbers alone: the decision depends entirely on personal conviction about Chinese geopolitical and regulatory risk, a factor no financial grid can measure on your behalf.

FAQ

What does Yuanbao do?

It distributes health and life insurance products online in China, connecting consumers to multiple insurance companies through a digital platform.

Why does Yuanbao trade so low despite a perfect score?

The market is pricing in a geopolitical and regulatory risk specific to Chinese stocks listed abroad (capital restrictions, delisting risk), beyond the company's fundamentals alone.

Is Yuanbao comparable to another stock already analyzed on this site?

Yes, its risk profile is similar to Futu Holdings, the Hong Kong-based online broker already analyzed on my site.

Is Yuanbao profitable?

Yes, for 13 straight quarters, with a 29.9% net margin and a 53.8% return on invested capital.

Should you invest in Yuanbao despite the discount?

That depends entirely on personal conviction about Chinese geopolitical and regulatory risk, a factor no financial grid can decide on the investor's behalf.

YB: see the full analysis on Lubin Investment

About the author

Written by Lubin Danilo, founder of Lubin Investment. A self-taught individual investor, I find fundamental analysis fascinating, and it has delivered excellent results. For three years now, my performance has beaten the S&P 500. But analyzing every stock took too much time: sites with incomplete data, calculation methods and criteria never aligned with mine. And spotting the best stocks was just as time-consuming, even with my own well-defined checklist. So I put my software development background to work to build this software, base my investment strategy on its results, and share it with people who share the same passion as me. It judges a company's quality and its price separately, using criteria drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran).